Bionano Genomics
BNGO
46 hedge funds and large institutions have $16M invested in Bionano Genomics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 65 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
0.11% less ownership
Funds ownership: 17.12% → 17.02% (-0.11%)
11% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $1.34M
50% less capital invested
Capital invested by funds: $32.1M → $16M (-$16.1M)
57% less funds holding
Funds holding: 108 → 46 (-62)
94% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 65
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$2.32M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.34M |
| 3 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
+$613K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$396K |
| 5 |
ACS
Archford Capital Strategies
Swansea,
Illinois
|
+$238K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$2.4M |
| 2 |
Millennium Management
New York
|
-$641K |
| 3 |
Charles Schwab
San Francisco,
California
|
-$445K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$337K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$325K |
BNGO Hedge Fund Activity: Q3 2023 in Review
46 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2023, worth a combined $16M — down 50% from $32.1M a quarter earlier.
Sellers outnumbered buyers: 65 funds closed out of BNGO and 4 opened new positions — a net loss of 61 holders — while 15 trimmed existing stakes and 19 added.
The largest buyer was GMT Capital, opening a new position worth an estimated $2.32M. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $2.4M sold.
- 46 institutional investors held Bionano Genomics (BNGO) as of Q3 2023, down from 108 in Q2 2023.
- Funds reported $16M of Bionano Genomics stock for Q3 2023, down 50% quarter-over-quarter.
- 4 funds opened new Bionano Genomics positions in Q3 2023 and 65 closed out, a net change of -61 holders.
- The largest Bionano Genomics buyer in Q3 2023 was GMT Capital, an estimated $2.32M added.
- The largest Bionano Genomics seller in Q3 2023 was Qube Research & Technologies (QRT), an estimated $2.4M sold.
Based on aggregated 13F filings for Q3 2023.